This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Andrew Chee-Yuen Chan: Innovator in Transgenic Research
Introduction
Andrew Chee-Yuen Chan is a prominent inventor based in Menlo Park, California. He is known for his significant contributions to the field of biotechnology, particularly in the development of transgenic animals. His work has implications for medical research and therapeutic applications.
Latest Patents
Andrew Chan holds a patent for "Transgenic mice expressing human CD20 and/or CD16." This invention relates to non-human transgenic animals that express human cellular markers, including CD20 and/or CD16. This innovation is crucial for advancing research in immunology and therapeutic development.
Career Highlights
Andrew Chan is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to contribute to groundbreaking research and advancements in the field.
Collaborations
Andrew has collaborated with notable colleagues, including Qian Gong and Flavius Martin. These collaborations have fostered a productive research environment, leading to significant advancements in their respective fields.
Conclusion
Andrew Chee-Yuen Chan's contributions to transgenic research exemplify the impact of innovative thinking in biotechnology. His work continues to influence the development of new therapies and enhance our understanding of human biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile